Codiak BioSciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Codiak BioSciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $10.08 per share as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2022-11-03
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $10.08.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $9.88.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $9.14.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $8.02.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2022-09-30 | $10.08 10-Q · filed 2022-11-03 |
| 2022-06-30 | $9.88 10-Q · filed 2022-08-04 |
| 2022-03-31 | $9.14 10-Q · filed 2022-05-05 |
| 2021-12-31 | $8.02 10-K · filed 2022-03-10 |
| 2021-09-30 | $7.75 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.05 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.87 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.52 10-K · filed 2021-03-17 |
| 2020-09-30 | $6.37 10-Q · filed 2020-11-19 |
| 2019-12-31 | $5.16 10-Q · filed 2020-11-19 |